D. E. Shaw & Co., Inc. Palatin Technologies Inc Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.34 - $0.86 $46,488 - $117,589	-136,732 Reduced 86.72%	20,933 $11,000
Q3 2021 Nov 15, 2021	BUY	$0.44 - $0.63 $69,372 - $99,328	157,665 New	157,665 $70,000
Q3 2019 Nov 14, 2019	SELL	$0.78 - $1.09 $14,118 - $19,729	-18,100 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.98 - $1.64 $17,738 - $29,684	18,100 New	18,100 $21,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.